Primary Progressive Aphasia (PPA) is a form of young onset dementia wherein language abilities are primarily impacted. There are three main recognised forms, each presenting with different language symptoms and neuropsychological profile.
The aim of this session is to provide a highly practical series of recommendations and guidelines for psychologists regarding how to structure interventions that assist people living with different forms of PPA by considering their broader neuropsychological profile.
An outline of word retrieval interventions will be discussed, with a specific focus on how to tailor stimuli and practices to enhance maintenance and retention of spoken vocabulary. In addition, education and support programs which aim to improve quality of life in people living with PPA will be discussed, including approaches both for individuals and for groups. The differing impacts of the three clinical phenotypes, at various levels of progression will be considered.
The goal of the session is to provide a summary of current evidence-based practice, practical steps to formulate effective, tailored treatment approaches and advice to provide families who support people with PPA.

Grief is a ubiquitous human experience that carries significant psychological impacts. However, traditional approaches to grief therapy may be ineffective when routinely offered to bereaved people (Neimeyer, 2016). Up to 10% of grieving individuals experience prolonged or ‘complicated’ grief with commensurate impairment in functioning and quality of life (Lundorff et al., 2017). The need for more effective approaches to assist grieving individuals is both a public health challenge and opportunity.

Early evidence suggests Induced After Death Communication (IADC) Therapy may be superior to traditional grief counselling (Holden et al, in press). It is also more brief than standard EMDR protocols. The present study sought to build on Holden and colleagues’ (in press) work evaluating IADC Therapy, a very brief treatment protocol derived from eye movement desensitisation and reprocessing (EMDR). We present the promising results of our waitlist-controlled trial evaluating the IADC protocol (2 x 90-minute therapy sessions) on individuals (n = 43) seeking assistance for the sadness and symptoms associated with grief, including an analysis of predictors of treatment response. Attendees will learn about IADC Therapy's history, current status, and its potential to advance grief therapy with significant public health benefits.